PEPFAR's annual planning process is done either at the country (COP) or regional level (ROP).
PEPFAR's programs are implemented through implementing partners who apply for funding based on PEPFAR's published Requests for Applications.
Since 2010, PEPFAR COPs have grouped implementing partners according to an organizational type. We have retroactively applied these classifications to earlier years in the database as well.
Also called "Strategic Areas", these are general areas of HIV programming. Each program area has several corresponding budget codes.
Specific areas of HIV programming. Budget Codes are the lowest level of spending data available.
Expenditure Program Areas track general areas of PEPFAR expenditure.
Expenditure Sub-Program Areas track more specific PEPFAR expenditures.
Object classes provide highly specific ways that implementing partners are spending PEPFAR funds on programming.
Cross-cutting attributions are areas of PEPFAR programming that contribute across several program areas. They contain limited indicative information related to aspects such as human resources, health infrastructure, or key populations programming. However, they represent only a small proportion of the total funds that PEPFAR allocates through the COP process. Additionally, they have changed significantly over the years. As such, analysis and interpretation of these data should be approached carefully. Learn more
Beneficiary Expenditure data identify how PEPFAR programming is targeted at reaching different populations.
Sub-Beneficiary Expenditure data highlight more specific populations targeted for HIV prevention and treatment interventions.
PEPFAR sets targets using the Monitoring, Evaluation, and Reporting (MER) System - documentation for which can be found on PEPFAR's website at https://www.pepfar.gov/reports/guidance/. As with most data on this website, the targets here have been extracted from the COP documents. Targets are for the fiscal year following each COP year, such that selecting 2016 will access targets for FY2017. This feature is currently experimental and should be used for exploratory purposes only at present.
Years of mechanism: 2012 2013
TB CARE I is a global USAID-funded Indefinite Quantity Contract (IQC) mechanism for TB control. TB-CARE I is implemented through a coalition of intl TB and public health institutions-the KNCV Tuberculosis Foundation, World Health Organization (WHO) and Managerial Sciences for Health (MSH). TB CARE I aims to improve the national TB prevention and control response through the following objectives: 1) Support GOE to achieve or exceed WHOs 70% case detection and 85% treatment success, 2) Enhance diagnosis and treatment of MDR-TB, 3) Reduce the case fatality rate among HIV-co-infected TB patients and 4) Ensure that TB is considered a public health priority. This is aligned with PF Goal 2.3: An increased number of individuals in all age groups access a continuum of quality comprehensive clinical HIV/AIDS care and treatment services, including TB/HIV by 2014 and GHI HHS strategy to strengthen TB services. TB CARE I focuses on strengthening the management and technical capacity of the Natl TB Control Program at the central and regional levels to ensure universal and early access to TB diagnosis and treatment, encourage TB/HIV collaborative activities, and strengthen programmatic management of drug-resistant TB and infection control.The health system will be strengthened through increased GOE stewardship and management as well as strengthened technical capacity & increased human resource development. This includes cost-effective and sustainable coordination mechanisms for all stakeholders involved for service provision, M & E and coordination of partners. National MDR-TB M & E tools with key indicators are being used and TB-CARE will work with WHO to develop a national electronic database. No additional vehicles are needed.
TB CARE I re-enforces the Health Sector Development Strategic Plan of the natl TB program by improving political commitment and management capacity at federal and regional levels as aligned with the PF and GHI strategy. Unlike Heal TB which focuses on service delivery in two geographic regions, TB CARE focuses on providing central level support to FMOH, EHNRI, RHBs and Regional Labs in the areas of capacity building, support for development/revision of guidelines and training, Programmatic Management of Drug-Resistant TB (PMDT), strengthened coordinated TB/HIV activities, infection control (IC) and operational research (OR). Coordination across partners is planned to: 1) Improve the mechanism to capture TB and TB/HIV data, strengthen the TB/HIV technical working group (TWG) and improve TB case detection; 2) Strengthen TB-IC program through training, surveillance, coordination, implementing natl guidelines and strengthening the capacity of regional program managers; 3) Expand PMDT by improving access to second-line drugs, MDR-TB surveillance, support to MDR-TB TWG and training of staff; 5) Facilitate a natl OR agenda and create mechanisms to conduct research and build capacity of partners to generate evidence for effective program implementation and 6) Strengthen drug supply and mgmt by supporting trainings, SOP implementation, sensitization workshops, quantification, forecasting and integrating anti-TB drugs distribution with ARV. The TB CARE partners support the regular review and reporting of data on the key interventions as defined by the global and natl program indicators. National M&E frameworks and tools are used to track progress towards the defined objectives and targets. As a global USAID TB IQC, TB CARE I builds on the accomplishments of TB CAP project which preceded it that strengthened the capacity of health facilities to expand access to TB, MDR-TB and HIV care through DOTs. TB CARE I will continue to support the TB and TB/HIV strategic plan implementation, the functioning of TB/HIV and PMDT TWGs and the Natl STOP TB partnership.
